Literature DB >> 35698662

Generalisations of a Bayesian decision-theoretic randomisation procedure and the impact of delayed responses.

S Faye Williamson1,2, Peter Jacko3,4, Thomas Jaki1,5.   

Abstract

The design of sequential experiments and, in particular, randomised controlled trials involves a trade-off between operational characteristics such as statistical power, estimation bias and patient benefit. The family of randomisation procedures referred to as Constrained Randomised Dynamic Programming (CRDP), which is set in the Bayesian decision-theoretic framework, can be used to balance these competing objectives. A generalisation and novel interpretation of CRDP is proposed to highlight its inherent flexibility to adapt to a variety of practicalities and align with individual trial objectives. CRDP, as with most response-adaptive randomisation procedures, hinges on the limiting assumption of patient responses being available before allocation of the next patient. This forms one of the greatest barriers to their implementation in practice which, despite being an important research question, has not received a thorough treatment. Therefore, motivated by the existing gap between the theory of response-adaptive randomisation (which is abundant with proposed methods in the immediate response setting) and clinical practice (in which responses are typically delayed), the performance of CRDP in the presence of fixed and random delays is evaluated. Simulation results show that CRDP continues to offer patient benefit gains over alternative procedures and is relatively robust to delayed responses. To compensate for a fixed delay, a method which adjusts the time horizon used in the optimisation objective is proposed and its performance illustrated.

Entities:  

Keywords:  Bayesian decision-theoretic model; Clinical trials; Delayed responses; Dynamic programming; Response-adaptive randomisation

Year:  2022        PMID: 35698662      PMCID: PMC7612844          DOI: 10.1016/j.csda.2021.107407

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   2.035


  31 in total

1.  A natural lead-in approach to response-adaptive allocation for continuous outcomes.

Authors:  Erin Donahue; Roy T Sabo
Journal:  Pharm Stat       Date:  2021-01-22       Impact factor: 1.894

Review 2.  Better decision making in drug development through adoption of formal prior elicitation.

Authors:  Nigel Dallow; Nicky Best; Timothy H Montague
Journal:  Pharm Stat       Date:  2018-03-30       Impact factor: 1.894

3.  Bandit strategies evaluated in the context of clinical trials in rare life-threatening diseases.

Authors:  Sofía S Villar
Journal:  Probab Eng Inf Sci       Date:  2017-06-07       Impact factor: 1.269

4.  Multi-armed Bandit Models for the Optimal Design of Clinical Trials: Benefits and Challenges.

Authors:  Sofía S Villar; Jack Bowden; James Wason
Journal:  Stat Sci       Date:  2015       Impact factor: 2.901

5.  Response-adaptive trial designs with accelerated Thompson sampling.

Authors:  Jixian Wang
Journal:  Pharm Stat       Date:  2021-02-14       Impact factor: 1.894

6.  A Bayesian adaptive design for clinical trials in rare diseases.

Authors:  S Faye Williamson; Peter Jacko; Sofía S Villar; Thomas Jaki
Journal:  Comput Stat Data Anal       Date:  2016-09-28       Impact factor: 1.681

7.  Response-adaptive randomization for multi-arm clinical trials using the forward looking Gittins index rule.

Authors:  Sofía S Villar; James Wason; Jack Bowden
Journal:  Biometrics       Date:  2015-06-22       Impact factor: 2.571

8.  Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial.

Authors:  Keith W Muir; Gary A Ford; Claudia-Martina Messow; Ian Ford; Alicia Murray; Andrew Clifton; Martin M Brown; Jeremy Madigan; Rob Lenthall; Fergus Robertson; Anand Dixit; Geoffrey C Cloud; Joanna Wardlaw; Janet Freeman; Philip White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-10-18       Impact factor: 10.154

9.  Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints.

Authors:  Adam L Smith; Sofía S Villar
Journal:  J Appl Stat       Date:  2017-06-28       Impact factor: 1.404

10.  Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.

Authors:  Thomas Burnett; Pavel Mozgunov; Philip Pallmann; Sofia S Villar; Graham M Wheeler; Thomas Jaki
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

View more
  2 in total

1.  Adaptive Decision Method in C3I System.

Authors:  Kun Gao; Hao Wang; Joanicjusz Nazarko; Marta Jarocka
Journal:  Comput Intell Neurosci       Date:  2022-08-19

2.  Some performance considerations when using multi-armed bandit algorithms in the presence of missing data.

Authors:  Xijin Chen; Kim May Lee; Sofia S Villar; David S Robertson
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.